Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Franz

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Neurology. Clinical Practice|December 20, 2018
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trialDavid N Franz, John A Lawson, Zuhal Yapici, et al.
Lancet (London, England)|September 11, 2016
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled studyJacqueline A French, John A Lawson, Zuhal Yapici, et al.
Annals of Neurology|November 25, 2004
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndromeYang Tang, Mark B Schapiro, David N Franz, et al.
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
Plos One|June 29, 2016
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 StudyDavid N Franz, Elena Belousova, Steven Sparagana, et al.
Epilepsia|July 16, 2013
Stiripentol in Dravet syndrome: results of a retrospective U.S. studyElaine C Wirrell, Linda Laux, David N Franz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2014
The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1J Chris Kingswood, Sergiusz Jozwiak, Elena D Belousova, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.
Molecular Cancer Research : MCR|July 16, 2017
Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive CellsChenggang Li, Xiaolei Liu, Yang Liu, et al.
Journal of Medical Genetics|April 6, 2017
<i>GRIN2B</i> encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspectsKonrad Platzer, Hongjie Yuan, Hannah Schütz, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Neurology. Clinical Practice|December 20, 2018
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trialDavid N Franz, John A Lawson, Zuhal Yapici, et al.
Lancet (London, England)|September 11, 2016
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled studyJacqueline A French, John A Lawson, Zuhal Yapici, et al.
Annals of Neurology|November 25, 2004
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndromeYang Tang, Mark B Schapiro, David N Franz, et al.
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
Plos One|June 29, 2016
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 StudyDavid N Franz, Elena Belousova, Steven Sparagana, et al.
Epilepsia|July 16, 2013
Stiripentol in Dravet syndrome: results of a retrospective U.S. studyElaine C Wirrell, Linda Laux, David N Franz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2014
The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1J Chris Kingswood, Sergiusz Jozwiak, Elena D Belousova, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndromeMichael R Pranzatelli, Elizabeth D Tate, Anna L Travelstead, et al.
Molecular Cancer Research : MCR|July 16, 2017
Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive CellsChenggang Li, Xiaolei Liu, Yang Liu, et al.
Journal of Medical Genetics|April 6, 2017
<i>GRIN2B</i> encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspectsKonrad Platzer, Hongjie Yuan, Hannah Schütz, et al.
Pageof 5